Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9 USD | +20.00% | +20.00% | +63.64% |
20/05 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
15/05 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+63.64% | 3.38Cr | |
+18.16% | 12TCr | |
+13.21% | 11TCr | |
-7.15% | 2.42TCr | |
+2.07% | 2.28TCr | |
-10.79% | 1.8TCr | |
-41.74% | 1.64TCr | |
-13.25% | 1.64TCr | |
+1.18% | 1.36TCr | |
+27.41% | 1.17TCr |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018